We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2011 by Taipei Medical University WanFang Hospital.
Recruitment status was:  Active, not recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01322685
First Posted: March 24, 2011
Last Update Posted: March 24, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Taipei Medical University WanFang Hospital
  Purpose
The purpose of this study is to study the Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens. Subjects are divided into two groups which are health group and Tuberculosis or lung cancer group in order to compare with the difference.

Condition
Tuberculosis Lung Cancer

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens

Resource links provided by NLM:


Further study details as provided by Taipei Medical University WanFang Hospital:

Estimated Enrollment: 40
Study Start Date: July 2010
Estimated Study Completion Date: June 2011
Groups/Cohorts
Health Group
Tuberculosis Group
Tuberculosis or lung cancer group

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   17 Years to 90 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Health people Tuberculosis or lung cancer
Criteria

Inclusion Criteria:

  • Health group: between 17 to 90 years old
  • Tuberculosis group: people who are tuberculosis or lung cancer patients and between 17 to 90 years old

Exclusion Criteria:

  • Women subjects are before or after the period within two days
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01322685


Locations
Taiwan
Taipei Medical University - WanFang Hospital
Taipei, Taiwan
Sponsors and Collaborators
Taipei Medical University WanFang Hospital
Investigators
Principal Investigator: Kuo-Sheng Hung Taipei Medical University WanFang Hospital
  More Information

Responsible Party: Kuo-Sheng Hung, Department of Neurosurgery, WanFang Hospital
ClinicalTrials.gov Identifier: NCT01322685     History of Changes
Other Study ID Numbers: 99042
First Submitted: March 23, 2011
First Posted: March 24, 2011
Last Update Posted: March 24, 2011
Last Verified: March 2011

Keywords provided by Taipei Medical University WanFang Hospital:
Tuberculosis
Lung cancer

Additional relevant MeSH terms:
Tuberculosis
Mycobacterium Infections
Actinomycetales Infections
Gram-Positive Bacterial Infections
Bacterial Infections